key: cord-0895243-vt1a1a8o
authors: Ebrahimi, M.; Nazari Harmooshi, N.; Rahim, F.
title: Diagnostic Utility of Antigen Detection Rapid Diagnostic Tests for Covid- 19: A Systematic Review and Meta-Analysis
date: 2021-04-05
journal: nan
DOI: 10.1101/2021.04.02.21254714
sha: fbff7bdda3f111a5b5e244ec9fbc7f159454ae68
doc_id: 895243
cord_uid: vt1a1a8o

Background: Early detection of coronavirus disease (COVID-19) infection to improve disease management, becomes the greatest challenge. Despite high sensitivity of RT-PCR, not only it was reported that 20-67% of infected patients have false negative results. Rapid diagnostic tests (RDTs) are widely used as a point-of-care test for SARS-CoV-2 detection in both pharyngeal and blood specimens. To be less time-consuming, not seem so costly, and requiring no special training make it more favorable, but the low sensitivity is the main limitation. Several reports indicated rapid test of blood and pharyngeal samples has the same sensitivity as the RT-PCR, but some reports have lower sensitivity especial in asymptomatic patients. Methods: In the present survey, we investigate the eligible studies for sensitivity and specificity of rapid tests and explore the factors that influence the result to help better diagnose COVID-19 infection. 20 studies met the inclusion criteria, which impose 33 different tests. Results: Our findings showed, type of sample, type of assay, time of sampling, and load of virus influence on sensitivity of RDTs. Conclusion: This research extends our knowledge of how to improve the sensitivity of RDTs to better diagnose of infected patients to address the controlling COVID-19 pandemic.

Early detection of coronavirus disease infection to improve disease management, becomes the greatest challenge. Real-time PCR (RT-PCR) was introduced as a gold standard test in the laboratory. Despite high sensitivity of RT-PCR, not only it was reported that 20-67% of infected patients have false negative results, but also RT-PCR cannot differentiate between infectious and non-infectious SARS-CoV-2 particles (1,2). Rapid diagnostic tests (RDTs) are widely used as a point-of-care test for SARS-CoV-2 detection in both pharyngeal and blood specimens. To be less timeconsuming, not seem so costly, and requiring no special training make it more favorable, but the low sensitivity is the main limitation. Additional to the rapid antigen (Ag) test, the rapid antibody (Ab) test was considered as a timely point-of-care test to detect IgG and IgM Abs in blood, plasma, and serum of patient with COVID-19 (3, 4) . In a recent study Ricks et al . analyzed the health system cost and health impact of using RDTs among hospitalization and mildly symptomatic patient with COVID-19, and report that despite the low sensitivity of RDTs compare with RT-PCR, is accompanied with "Ag-RDTs have the potential to be simultaneously more impactful with a lower cost per death and infectious person-days averted" (5) .

Several reports indicated rapid test of blood and pharyngeal samples has the same sensitivity as the RT-PCR, but some reports have lower sensitivity especial in asymptomatic patients (6) (7) (8) (9) (10) . These controversial results may be due to the different sample types or examined in different infection stages. In the present systematic review, we attempt to assess the diagnostic utility of antigen detection rapid diagnostic tests for covid-19 versus RT-PCR in a different type of samples and different stages of infection determine the usability of rapid tests in best time and sample.

This review was performed following the PRISMA (Preferred Reporting Items for Systematic reviews and Meta-Analyses) and MOOSE (Meta-analyses Of Observational Studies in Epidemiology) guidelines (11, 12) .

To evaluate the usability of rapid tests compare with RT-PCR, we systematically searched the electronic database, including Scopus, Medline/PubMed, EMBASE, Web of sciences findings beyond the included studies by assuming that the selected studies are random samples from a larger population (14) . To compare the sensitivity and specificity in RDTs compared with the RT-PCR, 95% confidence intervals (CI) were used. According to the heterogeneity test results, either Der Simonian's and Laird's random-effects method or Mantel-Haenszel's fixed-effects method were used to estimate the overall sensitivity and specificity and 95% confidence intervals (15) . Moreover, subgroup analysis was implemented based on the type of specimen (nasopharyngeal swab, throat washing and bronchoalveolar fluids, and Nasal sample), and symptomatic or asymptomatic patinates as an important variable which may cause heterogeneity between different samples or influence of onset of symptoms. The Egger's test was used to investigate small study effects due to potential publication bias (16, 17) . If there was statistical heterogeneity among the results, a further sensitivity analysis was conducted to determine the source of heterogeneity. After the significant clinical heterogeneity was excluded, the randomized effects model was used for meta-analysis. P < 0.05 was considered as statistical significance (2-sided). All data were analyzed using STAT 16 (STATA Corporation, College Station, Texas).

Overall, 783 studies were initially collected. After removing duplicated studies, 580 studies have remained. During screening titles and abstracts, 165 studies were considered potentially eligible. Subsequently, in full-text screening, 295 studies were excluded (Figure 1) . Finally, 20 studies met our inclusion criteria, which impose 33 different tests (including 26,056 patients, mea age range from 20.5 to 53.14 years).

Eleven studies (55%) evaluated nasopharyngeal swabs (5, 6, 8, (12) (13) (14) (15) (16) (17) (18) (19) (20) . Three of included studies investigated various types of samples with just one assay (18, 27, 28) , whereas other two articles examined one type of sample with different assays to comparing sensitivity and specificity (7, 9) . A single study performed a similar series of experiments but for rapid Abs tests with finger-stick whole-blood (10) , whereas other two studies were used the same rapid Abs tests from patient's serum (29, 30) . Characteristics of diagnostic values of included studies are shown in Table 1 . Forest plots illustrating sensitivity and specificity for each analysis are seen in Figure 2 . The results of Cochrane Q and I 2 statistics showed significant heterogeneity in sensitivity and specificity, so estimations of sensitivity and specificity were obtained using a random effect model. In All rights reserved. No reuse allowed without permission.

(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted April 5, 2021. ; https://doi.org/10.1101/2021.04.02.21254714 doi: medRxiv preprint further analysis, data were analyzed based on the type of sample and symptomatic or asymptomatic patients Table S1-S5 and Figure S1-S5. Summary ROC curves constructed for all assays based on Monte Carlo simulations are shown in Figure 3 . It did not apply to assessing the false results, because 7 studies (35%) did not focus on false results (7, 9, 18, 22, 28, (30) (31) (32) . Some of the current kinds of literature which focused on Ab rapid tests were excluded due to reporting the results as the separate sensitivity for IgG and IgM or analyzed data based on onset of symptoms (3, 33) .

Following broad speared spectrum of COVID-19 infection, identified infected patients and carriers as soon as possible help to better control pandemic. In this line, the RDTs and rapid Abs test for detecting patients were introduced by WHO in a short time. A large and growing body of literature has investigated these tests' usability based on their sensitivity and specificity compared to the RT-PCR. Inconsistency in reported results has heightened the need for a comprehensive search to achieving a reliable finding. In this regard, in the present survey, we investigate the eligible studies for sensitivity and specificity of rapid tests and explore the factors that influence the result to help better diagnose COVID-19 infection.

One important factor that influences the sensitivity of RDTs is a type of sample. Studies that evaluated different types of samples revealed that nasal examination swabs and saliva specimens for RDTs are associated with lower sensitivity (27) . Our results showed the most collected samples were nasopharyngeal swabs; in this line, it was shown examine nasopharyngeal swab, the sensitivity of RDTs results increases (9, 38) . After evaluating various specimens, Yamayoshi et al. found that soaking specimen directly to the lysing buffer can improve RDTs sensitivity (38) .

Our analysis has shown the higher sensitivity observes in infected patients with lower Ct value by RT-PCR. In fact, in asymptomatic patients or patients with lower viral load, the sensitivity of RDTs decreases (6, 8, 39) . In the subsequent analysis, Cerutti et al. examine the STANDARD Q COVID-19 Ags (R-Ag) among infected patients; they demonstrated that patients who were positive for R-Ag have higher viral load and lower Ct value are symptomatic, and this can be an explanation higher RDTs sensitivity in symptomatic subjects (19) . In contrast, Pilarowski et al. reported asymptomatic subjects should not All rights reserved. No reuse allowed without permission.

(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted April 5, 2021. ; https://doi.org/10.1101/2021.04.02.21254714 doi: medRxiv preprint rule out because regardless of symptoms, it can be possible asymptomatic patients have a viral load (40) . In this regard, to the assessment of RDTs sensitivity, Eshghifar et al. used various concentration of heat-inactivated COVID-19 virus to assess a cut-off detection for RDTs; their findings showed, they could not determine a cut-off and reported RDTs to be positive just in patients with high viral load (28); whereas CK Mak et al. by using cell culture, the limiting of detection for RDTs reported 18.57 (18) .

Additional to the RDTs, some writers compared the sensitivity of cell culture with RT-PCR for detecting COVID-19. Like the RDTs, the result showed that in cell culture with lowing viral load, the sensitivity reduces (8) . This can be explained by the fact that specimens with low viral load or Ct value >30 do not cultured, suggesting low infectivity of virus (41) .

Conducting RDTs with various assays is a serious discussion that can cause emerging different sensitivity. A study that set out to determine sensitivity of various assay for RDTs found different results for positive controls in different assays; which could offer the current methods detect different Ags and subsequently influence test accuracy (32) .

The possible interference of time of testing cannot be ruled out. Some researchers revealed that testing less than 5 days from the onset of symptoms increases sensitivity (8, 9, 22, 28) . It is inconsistent with previous reports that a load of infectious virus decreases after 7-10 days (9, 42) . In one recent well-known recent experiment, Albert et al. with considering the age of participants found the sensitivity of RDTs is lower in pediatrics than adults (8) . showed, the false positive is higher in pregnant women (29) . One reason for the low accuracy of the rapid Ab test can be pointed out to the short-term immunity in such patients (43) . All rights reserved. No reuse allowed without permission.

(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. Much of the current systematic and meta-analysis literature focused on the accuracy of serological tests, and as the expected, their findings have shown lower accuracy of serological tests (44) (45) (46) .

The main goal of the current study was to determine the accuracy of RDTs. This study has found that generally, as the expected, RDTs have lower sensitivity than RT-PCR; this issue is affected by several factors such as type of specimen, the timing of sampling, type of assay, and viral load. This research extends our knowledge of how to improve the sensitivity of RDTs to better diagnose of infected patients to address the controlling COVID-19 pandemic.

No funding was received for the present study. 

The authors declare no conflict of interest. All procedure performs in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or compare ethical strand.

All rights reserved. No reuse allowed without permission.

(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.

(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. 

Pathophysiology, Transmission, Diagnosis, and Treatment of Coronavirus Disease 2019 (COVID-19): A Review

Duration of infectiousness and correlation with RT-PCR cycle threshold values in cases of COVID-19

Evaluation of the usability of various rapid antibody tests in the diagnostic application for COVID-19

Development and Clinical Application of A Rapid IgM-IgG Combined Antibody Test for SARS-CoV-2 Infection Diagnosis

Quantifying the potential value of antigen-detection rapid diagnostic tests for COVID-19: A modelling analysis. medRxiv

Performance of a rapid antigen test in the diagnosis of SARS-CoV-2 infection

The Comparative Clinical Performance of Four SARS-CoV-2 Rapid Antigen Tests and Their Correlation to Infectivity In Vitro

Field evaluation of a rapid antigen test (Panbio TM COVID-19 Ag Rapid Test Device) for COVID-19 diagnosis in primary healthcare centres

Analytical performances of five SARS-CoV-2 whole-blood finger-stick IgG-IgM combined antibody rapid tests

Metaanalysis of observational studies in epidemiology: A proposal for reporting

The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration

Conducting a meta-analysis: Basics and good practices

Prevalence of all-cause mortality and suicide among bariatric surgery cohorts: A meta-analysis

Meta-analysis in clinical trials

Statistical aspects of the analysis of data from retrospective studies of disease

Measuring inconsistency in metaanalyses

Evaluation of rapid antigen test for detection of SARS-CoV-2 virus

Urgent need of rapid tests for SARS CoV-2 antigen detection: Evaluation of the SD-Biosensor antigen test for SARS-CoV-2

Potential Use of Antigen-Based Rapid Test for SARS-CoV-2 in Respiratory Specimens in Low-Resource Settings in Egypt for Symptomatic Patients and High-Risk Contacts

Field evaluation of a rapid antigen test (Panbio TM COVID-19 Ag Rapid Test Device) for COVID-19 diagnosis in primary healthcare centres

Panbio antigen rapid test is reliable to diagnose SARS-CoV-2 infection in the first 7 days after the onset of symptoms

Field evaluation of the performance of a SARS-CoV-2 antigen rapid diagnostic test in Uganda using nasopharyngeal samples

Low performance of rapid antigen detection test as frontline testing for COVID-19 diagnosis

Evaluation of a SARS-CoV-2 rapid antigen test: Potential to help reduce community spread?

Evaluation of a rapid antigen test (Panbio TM COVID-19 Ag rapid test device) for SARS-CoV-2 detection in asymptomatic close contacts of COVID-19 patients

Evaluation of the rapid antigen test Panbio COVID-19 in saliva and nasal swabs in a population-based point-of-care study

Evaluation of Analytical Performance of Seven Rapid Antigen Detection Kits for Detection of SARS-CoV-2 Virus

SARS-CoV-2 immunochromatographic IgM/IgG rapid test in pregnancy: A false friend?

Evaluation of two automated and three rapid lateral flow immunoassays for the detection of anti-SARS-CoV-2 antibodies

Clinical assessment of the Roche SARS-CoV-2 rapid antigen test

Limits and opportunities of sarscov-2 antigen rapid tests: An experienced-based perspective

Evaluation of performance of two SARS-CoV-2 Rapid IgM-IgG combined antibody tests on capillary whole blood samples from the fingertip

Performance characteristics of a rapid SARS-CoV-2 antigen detection assay at a public plaza testing site in San Francisco. medRxiv

Evaluation of Abbott BinaxNOW Rapid Antigen Test for SARS-CoV-2 Infection at Two Community-Based Testing Sites -Pima County

Urgent need of rapid tests for SARS CoV-2 antigen detection: Evaluation of the SD-Biosensor antigen test for SARS-CoV-2

Potential Use of Antigen-Based Rapid Test for SARS-CoV-2 in Respiratory Specimens in Low-Resource Settings in Egypt for Symptomatic Patients and High-Risk Contacts

All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. Comparison of Rapid Antigen Tests for COVID-19

Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19 . The COVID-19 resource centre is hosted on Elsevier Connect , the company ' s public news and information

Performance characteristics of a rapid SARS-CoV-2 antigen detection assay at a public plaza testing site in San Francisco

Comparison of the SARS-CoV-2 Rapid antigen test to the real star Sars-CoV-2 RT PCR kit

SARS-CoV-2, SARS-CoV, and MERS-CoV viral load dynamics, duration of viral shedding, and infectiousness: a systematic review and meta-analysis

Rapid Antibody-Based COVID-19 Mass Surveillance: Relevance, Challenges, and Prospects in a Pandemic and Post-Pandemic World

Diagnostic accuracy of serological tests for covid-19: Systematic review and metaanalysis

Systematic review with meta-analysis of the accuracy of diagnostic tests for COVID-19

Testing for SARS-CoV-2 (COVID-19): a systematic review and clinical guide to molecular and serological in-vitro diagnostic assays

No reuse allowed without permission. (which was not certified by peer review) is the author/funder